Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$519M |
| 2 |
Netflix
NFLX
|
+$448M |
| 3 |
Qualcomm
QCOM
|
+$280M |
| 4 |
Microsoft
MSFT
|
+$252M |
| 5 |
Broadcom
AVGO
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$453M |
| 2 |
ExxonMobil
XOM
|
+$234M |
| 3 |
GMS
GMS Inc
GMS
|
+$217M |
| 4 |
SKX
Skechers
SKX
|
+$201M |
| 5 |
Capital One
COF
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 17.99% |
| 3 | Industrials | 12.15% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Healthcare | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Caribou Biosciences
CRBU
$158M
| $2.82M | ﹤0.01% |
1,210,310
-97,045
| -7% | -$183K |
|
2677
McCormick & Company Voting
MKC.V
$13.6B
| $2.82M | ﹤0.01% |
42,237
+1,022
| +2% | +$71.6K |
|
2678
Cytokinetics
CYTK
$10.9B
| $2.82M | ﹤0.01% |
51,259
+19,173
| +60% | +$790K |
|
2679
AerCap
AER
$23.9B
| $2.82M | ﹤0.01% |
23,273
+1,864
| +9% | +$218K |
|
2680
LENSAR
LNSR
$66M
| $2.78M | ﹤0.01% |
224,934
| – | – |
|
2681
RGC Resources
RGCO
$232M
| $2.77M | ﹤0.01% |
123,666
+118
| +0.1% | +$2.59K |
|
2682
Check Point Software Technologies
CHKP
$13.6B
| $2.77M | ﹤0.01% |
13,398
+693
| +5% | +$140K |
|
2683
Northern Technologies International Corp
NTIC
$76.3M
| $2.76M | ﹤0.01% |
358,414
-2,046
| -0.6% | -$15.9K |
|
2684
Sana Biotechnology
SANA
$913M
| $2.76M | ﹤0.01% |
778,126
-216,679
| -22% | -$783K |
|
2685
Ionis Pharmaceuticals
IONS
$9.25B
| $2.76M | ﹤0.01% |
+42,217
| New | +$2.06M |
|
|
GRAL
2686
GRAIL Inc
GRAL
$2.87B
| $2.76M | ﹤0.01% |
46,649
-1,275
| -3% | -$48.7K |
|
2687
8x8 Inc
EGHT
$262M
| $2.75M | ﹤0.01% |
1,296,292
+12,183
| +0.9% | +$24.5K |
|
|
DGICB
2688
Donegal Group Class B
DGICB
$800M
| $2.74M | ﹤0.01% |
164,894
-732
| -0.4% | -$11.3K |
|
2689
Solid Biosciences
SLDB
$777M
| $2.74M | ﹤0.01% |
443,541
+221,203
| +99% | +$1.29M |
|
2690
Blue Ridge Bankshares
BRBS
$314M
| $2.72M | ﹤0.01% |
642,591
+102,279
| +19% | +$396K |
|
2691
Paysign
PAYS
$497M
| $2.71M | ﹤0.01% |
431,157
+139,700
| +48% | +$893K |
|
2692
USCB Financial Holdings
USCB
$414M
| $2.7M | ﹤0.01% |
154,958
+11,251
| +8% | +$193K |
|
2693
Centuri Holdings
CTRI
$2.76B
| $2.7M | ﹤0.01% |
127,705
+103,013
| +417% | +$2.19M |
|
|
SNBR
2694
DELISTED
Sleep Number
SNBR
| $2.7M | ﹤0.01% |
384,870
-23,874
| -6% | -$209K |
|
2695
Vera Bradley
VRA
$106M
| $2.7M | ﹤0.01% |
1,343,671
-185,885
| -12% | -$394K |
|
2696
Maravai LifeSciences
MRVI
$987M
| $2.69M | ﹤0.01% |
936,555
-6,084
| -0.6% | -$15.5K |
|
2697
Rigetti Computing
RGTI
$5.2B
| $2.67M | ﹤0.01% |
89,547
+54,186
| +153% | +$950K |
|
2698
Madrigal Pharmaceuticals
MDGL
$12.7B
| $2.66M | ﹤0.01% |
5,799
+1,929
| +50% | +$720K |
|
2699
Fate Therapeutics
FATE
$283M
| $2.64M | ﹤0.01% |
2,094,975
-342,754
| -14% | -$370K |
|
2700
Gaia
GAIA
$48.1M
| $2.62M | ﹤0.01% |
442,882
-941
| -0.2% | -$4.7K |
|
Similar funds
Dimensional Fund Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Dimensional Fund Advisors held 3,356 positions worth $466B, up 7.9% from $432B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q3 2025 filing shows 84 new, 1,582 increased, 1,511 reduced and 85 closed positions. Its largest new stake was Qiagen: 1,300,037 shares worth $58.1M. The largest sale was Hess, an estimated $453M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2025 buy was Qiagen: 1,300,037 shares worth $58.1M.
- Dimensional Fund Advisors added most to Chevron in Q3 2025, an estimated $519M increase.
- Dimensional Fund Advisors's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $234M.
- Dimensional Fund Advisors fully exited Hess in Q3 2025, selling an estimated $453M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $466B portfolio in Q3 2025.
- Dimensional Fund Advisors opened 84 new positions and closed 85 in Q3 2025.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $466B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.